These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 16700857

  • 1. The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
    Foulds J.
    Int J Clin Pract; 2006 May; 60(5):571-6. PubMed ID: 16700857
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of varenicline for smoking cessation.
    Hays JT, Ebbert JO, Sood A.
    Am J Med; 2008 Apr; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [Abstract] [Full Text] [Related]

  • 3. Nicotine dependence and smoking cessation.
    Tan L, Tang Q, Hao W.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 34(11):1049-57. PubMed ID: 19952392
    [Abstract] [Full Text] [Related]

  • 4. [New drugs; varenicline].
    van Bronswijk H, Dubois EA, Zitman FG, Cohen AF.
    Ned Tijdschr Geneeskd; 2007 Nov 10; 151(45):2503-4. PubMed ID: 18062594
    [Abstract] [Full Text] [Related]

  • 5. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR.
    Arch Intern Med; 2007 Nov 10; 166(15):1561-8. PubMed ID: 16908788
    [Abstract] [Full Text] [Related]

  • 6. Pharmacotherapy for tobacco dependence.
    Fant RV, Buchhalter AR, Buchman AC, Henningfield JE.
    Handb Exp Pharmacol; 2009 Nov 10; (192):487-510. PubMed ID: 19184660
    [Abstract] [Full Text] [Related]

  • 7. Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
    Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE.
    Trends Pharmacol Sci; 2007 Jul 10; 28(7):316-25. PubMed ID: 17573127
    [Abstract] [Full Text] [Related]

  • 8. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S, Patel PN.
    Cardiol Rev; 2007 Jul 10; 15(3):154-61. PubMed ID: 17438382
    [Abstract] [Full Text] [Related]

  • 9. The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
    Crunelle CL, Miller ML, Booij J, van den Brink W.
    Eur Neuropsychopharmacol; 2010 Feb 10; 20(2):69-79. PubMed ID: 19959340
    [Abstract] [Full Text] [Related]

  • 10. [Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
    Florek E, Piekoszewski W.
    Przegl Lek; 2008 Feb 10; 65(10):700-5. PubMed ID: 19189582
    [Abstract] [Full Text] [Related]

  • 11. Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
    Stapleton JA, Watson L, Spirling LI, Smith R, Milbrandt A, Ratcliffe M, Sutherland G.
    Addiction; 2008 Jan 10; 103(1):146-54. PubMed ID: 18028247
    [Abstract] [Full Text] [Related]

  • 12. The neurobiological basis for partial agonist treatment of nicotine dependence.
    Aveyard P.
    Int J Clin Pract; 2006 May 10; 60(5):507-8. PubMed ID: 16700843
    [No Abstract] [Full Text] [Related]

  • 13. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
    Shiffman S.
    Clin Ther; 2008 Aug 10; 30(8):1461-75. PubMed ID: 18803988
    [Abstract] [Full Text] [Related]

  • 14. [New tobacco dependence drug: Varenicline, partial agonist of alpha4beta2 acetylcholine-nicotine receptors].
    Králíková E.
    Cas Lek Cesk; 2006 Aug 10; 145(11):832-4. PubMed ID: 17168413
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
    Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD, Williams KE.
    Neuropharmacology; 2007 Mar 10; 52(3):985-94. PubMed ID: 17157884
    [Abstract] [Full Text] [Related]

  • 16. Treatment of nicotine dependence with Chantix (varenicline).
    Rankin KV, Jones DL.
    Tex Dent J; 2011 May 10; 128(5):457-61. PubMed ID: 21834368
    [Abstract] [Full Text] [Related]

  • 17. Developments in pharmacotherapy for tobacco dependence: past, present and future.
    Foulds J, Steinberg MB, Williams JM, Ziedonis DM.
    Drug Alcohol Rev; 2006 Jan 10; 25(1):59-71. PubMed ID: 16492578
    [Abstract] [Full Text] [Related]

  • 18. Nicotine gum dependence treated with varenicline--a case report.
    Garelik DA.
    Nicotine Tob Res; 2010 Oct 10; 12(10):1041-2. PubMed ID: 20829327
    [Abstract] [Full Text] [Related]

  • 19. Varenicline for smoking cessation.
    Tonstad S.
    Expert Rev Neurother; 2007 Feb 10; 7(2):121-7. PubMed ID: 17286546
    [Abstract] [Full Text] [Related]

  • 20. [Effectiveness and safety of varenicline for smoking cessation].
    Christalla P, Dewenter M, El-Armouche A.
    Dtsch Med Wochenschr; 2012 May 10; 137(18):940-4. PubMed ID: 22492478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.